Princess Imoukhuede

Last updated
Princess Imoukhuede
Born
Princess Izevbua Imoukhuede

1980 (age 44–45)
Alma mater Massachusetts Institute of Technology
California Institute of Technology
Awards National Science Foundation CAREER Award (2017)
Scientific career
Fields Systems Biology
Vascular Biology
Cellular and Molecular Bioengineering
Regenerative Medicine [1]
Institutions Washington University in St. Louis
Johns Hopkins University
University of Illinois at Urbana–Champaign
Thesis Visualizing the membrane confinement, trafficking and structure of the GABA transporter, GAT1  (2008)
Doctoral advisor Henry A. Lester [2]
Website imoukhuedelab.wustl.edu OOjs UI icon edit-ltr-progressive.svg

Princess Imoukhuede (pronounced I-muh-KWU-e-de) (born 1980) is an American chemical engineer who is a Professor in Bioengineering at the University of Washington as the Hunter and Dorthy Simpson Endowed Chair. [3] She conducts groundbreaking research on angiogenic signaling and vascular biology. Her lab employs quantitative systems biology to understand and control signaling networks driving blood-vessel formation, with the aim of developing treatments for diseases like cancer and cardiovascular disorders. Imoukhuede's work has earned her numerous awards, including the National Science Foundation CAREER Award and the Biomedical Engineering Society Mid-Career Award, and the Illinois Mathematics and Science Academy Distinguished Leadership Award and the 2018 Nano Research Young Innovators Award in Nanobiotechnology, recognizing her significant contributions to scholarship, education, and mentorship. Her first name is 'Princess' however, she holds no royal title or position in any capacity.

Contents

Early life and education

Imoukhuede grew up in Matteson, Illinois. [4] She was involved with track and field as a child, and competed in shot put from the age of eight. By the time she was in eighth grade she had become interested in science, and her parents gave her a chemistry set to play with at home. [5] Imoukhuede attended the Illinois Mathematics and Science Academy. [5] Imoukhuede was an undergraduate student in biomedical engineering at Massachusetts Institute of Technology (MIT), where she performed undergraduate research under the supervision of Robert S. Langer on the incorporation of adenoviruses in a liposome-based gene therapy system. In her freshman year she was honoured at the Eastern College Athletic Conference, and was the first woman from MIT to qualify for the National Collegiate Athletic Association.[ citation needed ] Whilst at MIT, Imoukhuede took part in athletics, serving as captain of the varsity track and field team, and was named an NCAA All-American athlete. Imoukhuede was described by Roger Crosley, then MIT Director of Sport, as "the best weight thrower we ever had in track and field".[ citation needed ] After earning her bachelor's degree, Imoukhuede moved to the California Institute of Technology, where she worked with Henry A. Lester on the structure of the GABA transporter and Förster resonance energy transfer. [2] She was the first African American woman to receive a PhD in bioengineering from Caltech. [3]

Research and career

Imoukhuede was a postdoctoral scholar at Johns Hopkins University, where she specialised in biomedical engineering in the laboratory of Aleksander Popel. [5] She was 1 of 10 postdoctoral fellows nationwide to earn the prestigious United Negro College Fund/Merk Postdoctoral Fellowship. During her fellowship, started working on the vascular endothelial growth factor (VEGF) and its receptor (VEGFR) in ischemia and cancer. After completing her postdoctoral research, Imoukhuede joined the University of Illinois at Urbana–Champaign. [6] Currently, Imoukhuede is a professor of bioengineering at the University of Washington as the Hunter and Dorthy Simpson Endowed Chair. [7]

Imoukhuede studies the mechanisms that regulate angiogenic signalling, including tyrosine kinase receptors, VEGF receptors and platelet-derived growth factor receptors. In 2019 Imoukhuede and Sarah K. England partnered to improve the efficacy and safety of oxytocin during labour. [8] Imoukhuede is developing a computational model that could be used to predict the function of oxytocin receptor function. [8] Her current focus is to unravel the complexities governing blood-vessel formation which gives the potential for treatment for several diseases such as breast cancer and some cardiovascular diseases. [9] As of 2025, Imoukhuede has been deriving a computational model to find the optimal dosage for oxytocin, especially during pregnancy. [10]

Awards and honours

Selected publications

Her publications [1] include:

Patents

References

  1. 1 2 Princess Imoukhuede publications indexed by Google Scholar OOjs UI icon edit-ltr-progressive.svg
  2. 1 2 Imoukhuede, Princess Izevbua (2008). Visualizing the membrane confinement, trafficking and structure of the GABA transporter, GAT1 (PhD thesis). Pasadena, California: California Institute of Technology. OCLC   437168185.
  3. 1 2 "Meet Princess Imoukhuede | UW Bioengineering". 2022-02-18. Retrieved 2023-10-17.
  4. ↑ "Princess Imoukhuede". MIT Spectrum. Retrieved 2020-10-21.
  5. 1 2 3 4 5 "410: Dr. Princess Imoukhuede: Making Sense of the Signaling Networks that Stimulate Blood Vessel Formation". People Behind the Science Podcast. 2017-08-14. Retrieved 2020-10-21.
  6. ↑ "Imoukhuede Systems Biology Laboratory" . Retrieved 2020-10-22.
  7. 1 2 Berger, Norbert (2022-02-18). "Meet Princess Imoukhuede | UW Bioengineering" . Retrieved 2024-03-20.
  8. 1 2 "Imoukhuede teams with England on $2.4M NIH grant". engineering.wustl.edu. 11 September 2019. Retrieved 2020-10-21.
  9. ↑ PBtS (2017-08-14). "410: Dr. Princess Imoukhuede: Making Sense of the Signaling Networks that Stimulate Blood Vessel Formation". People Behind the Science Podcast. Retrieved 2024-03-20.
  10. ↑ Dubey, Preeti; Fang, Yingye; Lionel Tukei, K.; Kuila, Shobhan; Liu, Xinming; Sahota, Annika; Frolova, Antonina I.; Reinl, Erin L.; Malik, Manasi; England, Sarah K.; Imoukhuede, Princess I. (2025-02-08). "Predicting oxytocin binding dynamics in receptor genetic variants through computational modeling". npj Women's Health. 3 (1) 10: 1–12. doi: 10.1038/s44294-025-00058-y . ISSN   2948-1716.
  11. ↑ "Princess Imoukhuede – Miniature Brain Machinery" . Retrieved 2024-03-20.
  12. ↑ Communications, Grainger Engineering Office of Marketing and. "Princess U II Imoukhuede". bioengineering.illinois.edu. Retrieved 2025-03-17.
  13. ↑ Communications, Grainger Engineering Office of Marketing and. "Princess U II Imoukhuede". bioengineering.illinois.edu. Retrieved 2025-03-17.
  14. ↑ Communications, Grainger Engineering Office of Marketing and. "Princess U II Imoukhuede". bioengineering.illinois.edu. Retrieved 2025-03-17.
  15. ↑ Communications, Grainger Engineering Office of Marketing and. "Princess U II Imoukhuede". bioengineering.illinois.edu. Retrieved 2025-03-17.
  16. ↑ Communications, Grainger Engineering Office of Marketing and. "Princess U II Imoukhuede". bioengineering.illinois.edu. Retrieved 2025-03-17.
  17. ↑ Communications, Grainger Engineering Office of Marketing and. "Princess U II Imoukhuede". bioengineering.illinois.edu. Retrieved 2025-03-17.
  18. ↑ Communications, Grainger Engineering Office of Marketing and. "Princess U II Imoukhuede". bioengineering.illinois.edu. Retrieved 2025-03-17.
  19. ↑ "NSF Award Search: Award#1653925 - CAREER: qBio+cBio=sBio; Identifying the role of cross-family signaling in angiogenesis". nsf.gov. Retrieved 2020-10-21.
  20. ↑ Communications, Grainger Engineering Office of Marketing and. "Princess Imoukhuede earns IMSA Distinguished Leadership Award". grainger.illinois.edu. Retrieved 2024-03-20.
  21. 1 2 "Princess Imoukhuede". www.aiche.org. 2020-07-21. Retrieved 2024-03-20.
  22. ↑ Napier, Douglas H. (1992). "Workbook of test cases for vapor cloud source dispersion models, By Steven R. Hanna and David Strimaitis for the Centre for Chemical Process Safety of the American Institute of Chemical Engineers 1989, 122 + xv pages". The Canadian Journal of Chemical Engineering. 70 (4). New York: American Institute of chemical Engineers: 831. doi:10.1002/cjce.5450700433. ISBN   0-8169-0455-3. ISSN   0008-4034.
  23. ↑ "Imoukhuede receives 2021 BMES Mid-Career Award". engineering.wustl.edu. 2021-09-20. Retrieved 2024-03-20.
  24. ↑ Drenan, Ryan M.; Nashmi, Raad; Imoukhuede, Princess; Just, Herwig; McKinney, Sheri; Lester, Henry A. (2008). "Subcellular Trafficking, Pentameric Assembly, and Subunit Stoichiometry of Neuronal Nicotinic Acetylcholine Receptors Containing Fluorescently Labeled α6 and β3 Subunits" . Molecular Pharmacology. 73 (1): 27–41. doi:10.1124/mol.107.039180. ISSN   0026-895X. PMID   17932221. S2CID   14327818.
  25. ↑ Imoukhuede, P.I.; Popel, Aleksander S. (2011). "Quantification and cell-to-cell variation of vascular endothelial growth factor receptors". Experimental Cell Research. 317 (7): 955–965. doi:10.1016/j.yexcr.2010.12.014. ISSN   0014-4827. PMC   3073416 . PMID   21185287.
  26. ↑ Finley, Stacey D; Engel-Stefanini, Marianne O; Imoukhuede, PI; Popel, Aleksander S (2011). "Pharmacokinetics and pharmacodynamics of VEGF-neutralizing antibodies". BMC Systems Biology. 5 (1): 193. doi: 10.1186/1752-0509-5-193 . ISSN   1752-0509. PMC   3229549 . PMID   22104283.
  27. ↑ Rubin, Joshua B; Lagas, Joseph S; Broestl, Lauren; Sponagel, Jasmin; Rockwell, Nathan; Rhee, Gina; Rosen, Sarah F; Chen, Si; Klein, Robyn S; Imoukhuede, Princess; Luo, Jingqin (2020). "Sex differences in cancer mechanisms". Biology of Sex Differences. 11 (1): 17. doi: 10.1186/s13293-020-00291-x . ISSN   2042-6410. PMC   7161126 . PMID   32295632.
  28. ↑ Communications, Grainger Engineering Office of Marketing and. "Princess U II Imoukhuede". bioengineering.illinois.edu. Retrieved 2025-03-17.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.